Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fishbane

Showing results (251-260 of 357) with videos related to

Pageof 36
Sort By:
Clinical Transplantation|July 21, 2015
Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysisAditya Kadiyala, Anna T Mathew, Mala Sachdeva, et al.
American Journal of Nephrology|July 31, 2020
COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case SeriesMala Sachdeva, Nupur N Uppal, Jamie S Hirsch, et al.
Kidney International Reports|February 12, 2020
The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKDVipul Sakhiya, Joji James, Kenar D Jhaveri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2008
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patientsSteven M Brunelli, Marshall M Joffe, Rubeen K Israni, et al.
Kidney International|August 19, 2020
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Jia H Ng, Jamie S Hirsch, Rimda Wanchoo, et al.
American Journal of Nephrology|November 28, 2014
Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysisAnna T Mathew, Azzour Hazzan, Kenar D Jhaveri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patientsJeffrey S Berns, Steven Fishbane, Hafez Elzein, et al.
Kidney International Reports|May 5, 2018
Potentially Avoidable Readmissions in United States Hemodialysis PatientsAnna T Mathew, Lisa Rosen, Renee Pekmezaris, et al.
Seminars in Dialysis|January 21, 2006
How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?Kathleen L Wyne, Steven Fishbane, Geoffrey A Block, et al.
Pageof 36

Showing results (251-260 of 357) with videos related to

Sort By:
Pageof 36
Clinical Transplantation|July 21, 2015
Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysisAditya Kadiyala, Anna T Mathew, Mala Sachdeva, et al.
American Journal of Nephrology|July 31, 2020
COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case SeriesMala Sachdeva, Nupur N Uppal, Jamie S Hirsch, et al.
Kidney International Reports|February 12, 2020
The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKDVipul Sakhiya, Joji James, Kenar D Jhaveri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2008
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patientsSteven M Brunelli, Marshall M Joffe, Rubeen K Israni, et al.
Kidney International|August 19, 2020
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Jia H Ng, Jamie S Hirsch, Rimda Wanchoo, et al.
American Journal of Nephrology|November 28, 2014
Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysisAnna T Mathew, Azzour Hazzan, Kenar D Jhaveri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patientsJeffrey S Berns, Steven Fishbane, Hafez Elzein, et al.
Kidney International Reports|May 5, 2018
Potentially Avoidable Readmissions in United States Hemodialysis PatientsAnna T Mathew, Lisa Rosen, Renee Pekmezaris, et al.
Seminars in Dialysis|January 21, 2006
How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?Kathleen L Wyne, Steven Fishbane, Geoffrey A Block, et al.
Pageof 36